Search

Italy: Pharma Packaging Bormioli Pharma Acquires GCL Pharma

| Editor: Ahlam Rais

With this acquisition, Bormioli Pharma is expanding its technological platform in order to offer new solutions to the product range offered in the market for parenteral and oral drugs. The move will also strengthen its role as a leading partner for the global pharmaceutical industry.

GCL Pharma will be completely integrated within the Bormioli Pharma group and will change its business name to Bormioli Pharma Vasto.
GCL Pharma will be completely integrated within the Bormioli Pharma group and will change its business name to Bormioli Pharma Vasto.
(Source: Deposit Photos)

Parma/Italy – Bormioli Pharma, one of the leading manufacturers of primary packaging for the pharmaceutical industry, has successfully completed the acquisition of 100 % of GCL Pharma. GCL Pharma is an Italian company based in Vasto (Chieti) previously part of Guala Closures Group and specialised in the production of rubber stoppers and aluminum closures for pharmaceutical applications.

This represents a new significant step in the growth path that Bormioli Pharma has started with the acquisition of the German company Remy & Geiser last autumn, and the recent investments in the industrial sites of Bergantino (Rovigo) and San Vito al Tagliamento (Pordenone). The company is expanding its technological platform adding new solutions to the product range offered to the market, also strengthening its role as leading partner for the global pharmaceutical industry.

Specialist Book „Heat Transfer Technique“The comprehensive standard work „Heat Transfer Technique“ offers not only a detailed and well-founded presentation of the basics of heat transfer technique, but also shows the latest state of the art and the latest regulations in the use of organic fluids. Thematically, the book is rounded off with an overview of property data of organic heat transfer fluids as well as many use cases from practical experience.

GCL Pharma will be completely integrated within the Bormioli Pharma group and will change its business name to Bormioli Pharma Vasto.

"We are proud to welcome our new colleagues in the Bormioli Pharma Group,” says Andrea Lodetti, CEO of Bormioli Pharma. "This acquisition brings along new technologies and professional expertise and will enable us to expand and complete our offer of primary pharmaceutical packaging, in particular for parenteral applications. We have already planned significant industrial investments for our plant in Vasto that will boost the development and activation of operational and commercial synergies, increasing the level of service to our customers.”

"Becoming part of the Bormioli Pharma Group represents an opportunity to grow at the international level and to enhance our product innovation capabilities within the Pharma industry,” affirms Fabio Rastelli, Site Manager of Bormioli Pharma Vasto.

(ID:46520993)